mdlinx mdlinx

Pharma News Articles

MDLinx Pharma helps physicians and healthcare professionals stay up to date with the latest pharma news articles and research, as well as pharma jobs, conferences, and resources.

Your Unread Messages in Pharma News

See All >> Messages include industry-sponsored communications and special communications from MDLinx


Latest (24) Full Text Articles (547)
Ranked, sorted, and summarized by MDLinx editors from the latest literature

1 Abbvie submits new drug application to U.S. FDA for its investigational, all-oral, interferon-free therapy for the treatment of hepatitis C Full Text AbbVie, April 23, 2014

2 FDA grants orphan drug designation for bayers investigational ciprofloxacin DPI (dry powder for inhalation) for treatment of non-cystic fibrosis bronchiectasis Full Text Bayer HealthCare Pharmaceuticals, April 23, 2014

3 GSK plc announces major three-part transaction with Novartis to drive sustainable sales growth, improve long-term earnings and deliver increasing returns to shareholders Full Text GlaxoSmithKline, April 23, 2014

4 Pfizer announces positive top-line results from two phase 3 trials of tofacitinib in adults with moderate-to-severe chronic plaque psoriasis Full Text Pfizer, April 23, 2014

5 Amgens first quarter 2014 revenues increased 7 percent to $4.5 billion Full Text Amgen, April 23, 2014

6 Valeant proposes to combine with Allergan for $48.30 in cash and 0.83 shares of Valeant stock for each Allergan share Full Text Valeant Pharmaceuticals International, April 23, 2014

7 Lillys CYRAMZA (ramucirumab) becomes first FDA-approved treatment for advanced gastric cancer after prior chemotherapy Full Text Eli Lilly and Company, April 23, 2014

8 Sarepta therapeutics announces proposed public offering of common stock Full Text Sarepta Therapeutics, April 23, 2014

9 GSK and Theravance announce phase III study of fluticasone furoate/vilanterol in COPD commenced to support potential future filing in Japan Full Text GlaxoSmithKline, April 23, 2014

10 Bristol-Myers Squibb and Samsung BioLogics expand manufacturing agreement Full Text Bristol Myers-Squibb, April 23, 2014

11 ZZ Biotech announces phase 2 trial with 3K3A-APC in stroke; funds will be provided by NIH and broadview ventures Full Text B3C newswire, April 23, 2014

12 Aspireo reports data in further phase Ib study Full Text B3C newswire, April 23, 2014

13 Boston scientific begins clinical trial of ACUITY X4 LV pacing leads and RELIANCE 4-FRONT ICD leads Full Text Boston Scientific, April 23, 2014

14 Lilly announces agreement to acquire Novartis animal health Full Text Eli Lilly and Company, April 23, 2014

15 ET-743 (trabectedin), a novel antitumor agent meets primary endpoint of progression free survival prolongation in a phase 2 trial in malignant soft tissue sarcoma patients Full Text Taiho Pharmaceutical, April 23, 2014

16 Allergan confirms receipt of unsolicited proposal from Valeant Full Text Allergan, April 23, 2014

17 Cytokinetics announces results from BENEFIT-ALS will be presented at the 66th annual meeting of the American Academy of Neurology Full Text Cytokinetics, April 23, 2014

18 Salix pharmaceuticals to Present at ROTH conference Full Text Salix Pharmaceuticals, April 23, 2014

19 Johns Hopkins scientists alter fat metabolism in animals to prevent most common type of heart disease Johns Hopkins Medicine, April 23, 2014

20 Cubist pharmaceuticals reports first quarter 2014 financial results Full Text Cubist Pharmaceuticals, April 23, 2014

50 available pages FirstPrevious 1 2 3 4 5 6 7 8 9 10 Next Last

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Pharma Articles

Last month's top read Top Articles of 2013

1 Rentschler announces 3rd industrial cell culture technology conference on processes for virus-based biologics B3C newswire, March 17, 2014    Free full text

2 Treatment for rare metabolic disease approved Drug Topics, March 3, 2014    Free full text

3 GSK and Theravance announce positive results from studies comparing ANORO ELLIPTA with SERETIDE DISKUS and ADVAIR DISKUS in patients with COPD GlaxoSmithKline, March 17, 2014    Free full text

4 FDA details national vaccine plan BioPharm International, March 12, 2014    Free full text

5 Ranbaxy suspends API shipments from two plants in India BioPharm International, February 26, 2014    Free full text

6 First U.S. clinical site opens for CEL-SCIS global phase III immunotherapy head and neck cancer trial expansion CEL-SCI, March 5, 2014    Free full text

7 Biotechnology industry prospects remain strong First Report Managed Care, March 21, 2014    Free full text

8 Merck announces results from phase 2b study of MK-8237, an investigational house dust mite sublingual allergen immunotherapy tablet Merck, March 5, 2014    Free full text

9 Hailey-Hailey disease responding to thalidomide Indian Journal of Dermatology, March 6, 2014    Free full text

10 What do pharmas "High Performers" have in common? Pharmaceutical Executive Magazine, March 10, 2014    Free full text

11 Bristol-Myers Squibb presents promising phase IIb data for novel, investigational attachment inhibitor for HIV-1 infected treatment-experienced patients Bristol Myers-Squibb, March 7, 2014    Free full text

12 Formycon AG: Licensing out of the first biosimilar development project already enables extension of the product pipeline as of 2014 B3C newswire, March 13, 2014    Free full text

13 FDA allows marketing of first medical device to prevent migraine headaches FDA Press Announcements, March 13, 2014    Free full text

14 Sirturo (bedaquiline) receives conditional approval in the European union for the treatment of multi-drug resistant tuberculosis Johnson & Johnson, March 7, 2014    Free full text

15 AAAAI 2014ASTHMA: New phase III data show tiotropium respimat effective across asthma severities Boehringer Ingelheim, March 3, 2014    Free full text

16 Sanofis board of directors propose appointment of Patrick Kron as new independent director Sanofi, March 6, 2014    Free full text

17 Research and publication trends in hospital medicine Journal of Hospital Medicine, March 11, 2014    Evidence Based Medicine

18 Fda approves vibativ for hospitalized patients with bacterial pneumonia FDA Press Announcements, June 25, 2013    Free full text

19 FDA releases guidance on CMC postapproval changes BioPharm International, March 5, 2014    Free full text

20 UPLC system for nano- to microscale separations BioPharm International, March 19, 2014    Free full text

Indexed Journals in Pharma News: U.S.Pharmacist, FDA Drug Alerts, Pharmiwebmore

Other Topics in Pharma News

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register
Upcoming Clinical Trials UPCOMING Clinical Trials

Stay current - Media Tool


Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More